H. Pylori Eradication Using Pyklear in Adults in El Paso, Texas: a Pilot Study

Summary

The proposed open-label one arm before-after clinical trial will assess the efficacy of a 14-day quadruple therapy containing 420mg of bismuth subcitrate potassium, 375mg of metronidazole, 375mg of tetracycline hydrochloride (Pylera® packs from Axcan Pharma) and 20mg of omeprazole in eradicating H. pylori infection in 50 asymptomatic adults in El Paso, Texas. As part of the study we will obtain specimens for culture of H. pylori in a reference laboratory.

Timeline

Start

2011-03

Primary completion

2011-06

Completion

2011-08

Drugs

Indications